Ro earned unicorn status with a $200 million funding haul
published 29.07.2020 17:09
However, 98point6 CEO Robbie Cape recently told us that health plans may revert back to reimbursing telehealth visits at a lower rate than in-office visits post-pandemic — and clinics will likely urge patients to opt for in-office visits.In this case, we'll expect to see consumers eye standalone providers — like Ro and 98point6— that can continue meeting their demand for virtual care.
Telehealth firms that diversify their offerings will be well positioned to hold consumer appetite post-pandemic — especially as uncertainty around telehealth reimbursements makes it unclear whether traditional providers will continue to embrace virtual care.
Business Insider Intelligence Ro owns three digital health clinics that focus on 20 treatment areas like sexual health and addiction treatment, and it launched Ro Pharmacy, a virtual pharmacy that offers 500 generic medications for $5 per month and a digital telehealth platform where patients can connect with a physician for $15.
Ro, a three-year-old telehealth startup, earned unicorn status with a $200 million funding haul it'll use to expand its remote monitoring services.
As such, we wouldn't be surprised if telehealth companies offering diverse services at a more affordable rate than in-person visits continue to attract droves of consumers beyond the pandemic.